New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified. [electronic resource]
- Journal of cancer research and clinical oncology Mar 2020
- 605-619 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-020-03144-7 doi
Animals Antineoplastic Agents--pharmacology Biomarkers, Tumor--analysis Breast Neoplasms--metabolism Electric Impedance Female Humans Mice Receptor, ErbB-2--metabolism Signal Transduction--physiology Xenograft Model Antitumor Assays